A detailed history of Financial Management Professionals, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 384 shares of BMY stock, worth $22,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
384
Previous 313 22.68%
Holding current value
$22,606
Previous $13,000 53.85%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$39.66 - $51.75 $2,815 - $3,674
71 Added 22.68%
384 $20,000
Q2 2024

Jul 12, 2024

BUY
$40.25 - $52.99 $4,950 - $6,517
123 Added 64.74%
313 $13,000
Q1 2024

Apr 16, 2024

SELL
$47.98 - $54.4 $3,886 - $4,406
-81 Reduced 29.89%
190 $10,000
Q4 2023

Jan 12, 2024

SELL
$48.48 - $57.85 $161,050 - $192,177
-3,322 Reduced 92.46%
271 $14,000
Q3 2023

Oct 13, 2023

SELL
$57.89 - $64.73 $27,381 - $30,617
-473 Reduced 11.63%
3,593 $209,000
Q2 2023

Jul 10, 2023

SELL
$63.71 - $70.74 $84,224 - $93,518
-1,322 Reduced 24.54%
4,066 $260,000
Q1 2023

Apr 13, 2023

BUY
$65.71 - $74.53 $63,147 - $71,623
961 Added 21.71%
5,388 $373,000
Q4 2022

Jan 11, 2023

BUY
$68.48 - $81.09 $34,171 - $40,463
499 Added 12.7%
4,427 $319,000
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $190 - $112,416
-1,463 Reduced 27.14%
3,928 $279,000
Q2 2022

Jul 12, 2022

BUY
$72.62 - $79.98 $16,121 - $17,755
222 Added 4.29%
5,391 $415,000
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $176,201 - $211,281
2,866 Added 124.45%
5,169 $378,000
Q4 2021

Jan 28, 2022

SELL
$53.63 - $62.52 $1,555 - $1,813
-29 Reduced 1.24%
2,303 $144,000
Q3 2021

Nov 02, 2021

BUY
$59.17 - $69.31 $7,337 - $8,594
124 Added 5.62%
2,332 $138,000
Q2 2021

Aug 05, 2021

BUY
$61.91 - $67.42 $15,353 - $16,720
248 Added 12.65%
2,208 $148,000
Q1 2021

Apr 26, 2021

BUY
$59.34 - $66.74 $32,518 - $36,573
548 Added 38.81%
1,960 $124,000
Q4 2020

Feb 03, 2021

SELL
$57.74 - $65.43 $5,543 - $6,281
-96 Reduced 6.37%
1,412 $88,000
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $402 - $445
7 Added 0.47%
1,508 $91,000
Q2 2020

Jul 21, 2020

BUY
$54.82 - $64.09 $67,099 - $78,446
1,224 Added 441.88%
1,501 $88,000
Q1 2020

Apr 24, 2020

SELL
$46.4 - $67.43 $2,366 - $3,438
-51 Reduced 15.55%
277 $15,000
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $6,249 - $8,152
127 Added 63.18%
328 $21,000
Q3 2019

Oct 11, 2019

BUY
$42.77 - $50.71 $2,181 - $2,586
51 Added 34.0%
201 $10,000
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $8,284 - $9,561
150
150 $9,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.